Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

Impressions : 966

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 903

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1098

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

The New Year began with two mid-size deals centered around the use of artificial intelligence (AI) in drug development. Sanofi...

Impressions : 905

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

Vis' Yuvezzi Receives Approval in US

SKG Pharma's Generics Sertraline HCl Receives Approval in US

Eugia Pharma's Generics Mesna Receives Approval in US

Sun Pharm Inds' Generics Deflazacort Receives Approval in US

Mankind Pharma's Generics Propranolol HCl Receives Approval in US

MSN's Generics Metformin HCl Receives Tentative Approval in US

Humanwell's Generics Tapentadol HCl Receives Approval in US

Caplin's Generics Methylprednisolone Receives Approval in US

I 3 Pharms' Generics Tranexamic Acid Receives Approval in US

Aurobindo's Generics Betamethasone Receives Approval in US

FDA Issues Form 483 to InnoStar Bio-Tech Nantong

FDA Issues Form 483 to JKR Pharmacy Ventures

Enforcement Report - Week of January 28, 2026

Center For Immunology's Receives FDA Warning Letter

Fulijaya Manufacturing SDN BHD's Receives FDA Warning Letter

FDA Issues Form 483 to Empower Clinic Services dba Empower Pharma

FDA Issues Form 483 to Denver Solutions

FDA Issues Form 483 to Asahi Kasei Finechem Co.

FDA Issues Form 483 to Petscript

FDA Issues Form 483 to Pine Pharmaceuticals

WHO sees low risk of Nipah virus spreading beyond India

AstraZeneca returns to China's CSPC for $18.5B obesity dea

CHMP Backs Sanofi's Rezurock for EU Chronic GVHD Approval

FDA Approves Shilpa & mAbTree Therapy for Rare Blood Disorder

Senate's ICE Dispute Delays Rare Disease Voucher Program

Indoco Remedies Gets USFDA Nod To Sell Generic Epilepsy Medicine

Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants

Minimum Import Price Set For Penicillin G, Salts

Medical Device Sector Anticipates Benefits From India-EU FTA

Alps Group Announces Potential Pipeline Expansion Beyond CELESOME

Indoco Remedies Gets USFDA Nod To Sell Generic Epilepsy Medicine

Alembic Gets USFDA Nod For Difluprednate Ophthalmic Emulsion

U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

Sun Pharma Receives DCGI Approval For Generic Semaglutide

MNC's Cancer Drug Patent Rejected, Allowing Generics Entry

Aspire Biopharma Files Patent for Sublingual Generic Xanax(R)

SEC Recommends Three Firms For Semaglutide Formulations

Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug

Zydus Receives Final Approval From USFDA For Eltrombopag Tablets

Apiject Opens U.S. Generic Injectable Facility in Apex, NC

Alps Group Announces Potential Pipeline Expansion Beyond CELESOME

FDA's Multiple Myeloma Guidance Highlights Decade Of Success

IPeace Unveils Human iPS Cells from NKT Cells

Tonix Pharma: Resilient Tonmya Data at 2026 Pain Conference

FDA Accepts BLA for Ivonescimab Combo in NSCLC Post-TKI Therapy

Sanofi Shifts From mRNA Flu Vaccine As CEO Shows Confidence

Promis Neurosciences Reveals $175M Private Placement Financing

Lyon Court Approves Poxel SA Recovery Plan, Ending Proceedings

Polaryx Therapeutics Secures Nasdaq Nod for Common Stock

Olema Oncology Cfo And Coo Departure Announced

Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants

Wanbury Reveals Tanuku API Facility, Aims For Rs. 100 Crore

Minimum Import Price Set For Penicillin G, Salts

Siegfried to acquire high-quality small molecules drug substance

Minakem becomes DMF holder for five additional APIs

Korean CDMO ST Pharm Signs $56M Contract For API Production

HRV Pharma, Haleos Labs Partner on Partner on Orphan & niche APIs

Narmafotinib Large-Scale Manufacturing Complete

CDSCO OKs Most New r-DNA Drugs for 2025 Import & Manufacture

Sigachi Industries Reaches Key R&D Milestone In Cystic Fibrosis

Haryana FDA Conducts Large-Scale Raid On Fatehabad Pharmacies

Allopathic Taint Triggers 'X-Plus Gold' Ayurvedic Recall

Drug Misuse: Govt May Curb 'Pregabalin' Sales

Neogen Recalls Neogen Vet HYCOAT Hyaluronate Sodium Nationwide

China Halts Sale of Sun Pharma Drug Used to Treat Dementia

Sun Pharma, Cipla Recall U.S. Products Over Manufacturing Issues

NIH bans use of aborted fetal tissue in research

Haryana FDA Seizes Tapentadol And Pregabalin Stock In Sirsa

IPC Developing IP Reference Standards For Anti-Tb Drug

Over 160 Drug Samples Found Sub-Standard In December

WHO sees low risk of Nipah virus spreading beyond India

Medical Device Sector Anticipates Benefits From India-EU FTA

DBT Establishes Bio-AI Hubs For Ayurveda & Genome Diagnostics